Kodak pharma agreement on hold following stock inquiries

0
421

Since the announcement of an investigation, Kodak has launched their own internal review to look into the loan deal. It is unknown whether an internal investigation will bear any fruit, or if this is simply a PR move to save face.

White House economic advisor Peter Navarro commented on the situation by applauding DFC’s decision to halt negotiations, claiming he was “VERY disappointed last week’s great deal with Kodak tarnished by allegations.”

Signup for the USA Herald exclusive Newsletter

While insider trading allegations certainly make for bad PR, it remains to be seen whether any investigation will lead to legal action. Furthermore, the SEC has not announced any findings related to the matter.

There certainly is a chance that Kodak will walk away from the investigation unscathed. Until the investigation is completed, it appears the once-great imaging giant will be treading water.

————————————————–

Have a story you want USA Herald to cover? Submit a tip here and if we think it’s newsworthy, we’ll follow up on it.